MS-Specific Internet-Based Therapy Program Can Cut Depressive Symptoms
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
TUESDAY, Oct. 17, 2023 -- A multiple sclerosis (MS)-specific internet-based cognitive behavioral therapy (iCBT) program can reduce depressive symptoms among patients with MS, according to a study published in the October issue of The Lancet Digital Health.
Stefan M. Gold, Ph.D., from Charité-Universitätsmedizin Berlin, and colleagues conducted a randomized controlled trial of an iCBT program to reduce depressive symptoms in patients with MS at five academic centers. Patients with a neurologist-confirmed diagnosis of MS and depressive symptoms were randomly assigned to treatment as usual plus one of two versions of the iCBT program Amiria (standalone or therapist-guided) or to a control condition in which participants were offered access to iCBT after six months. Of the participants, 101, 85, and 93 were allocated to receive standalone iCBT, guided iCBT, and the control condition, respectively.
The researchers found that compared with the control group, both versions of the iCBT program significantly reduced depressive symptoms (Beck Depression Inventory-II between-group mean differences: 6.32 points for control versus standalone and 5.80 points for control versus guided iCBT). Three participants in the control group, one in the standalone iCBT group, and none in the guided iCBT group experienced clinically relevant worsening of depressive symptoms. There were no occurrences of suicidality reported during the trial, nor any deaths.
"This remote-access, scalable intervention increases the therapeutic options in this patient group and could help to overcome treatment barriers," the authors write.
Several authors disclosed ties to industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted October 2023
Read this next
Teens May Experience Delays in Bipolar Progression After Major Depressive Disorder
FRIDAY, May 31, 2024 -- Adolescents may experience delayed bipolar disorder (BD) progression after major depressive disorder (MDD) diagnosis, according to a study published online...
Teen Smartphone Use Positively Tied to Mood
THURSDAY, May 30, 2024 -- Adolescent smartphone use is positively associated with mood, according to a study published online May 29 in PLOS ONE. Matt Minich, Ph.D., and...
Self-, Partner-Reported Cognitive Decline Linked to Tau
THURSDAY, May 30, 2024 -- Individuals who self-report and whose partners report cognitive decline have greater tau, which is driven by elevated beta-amyloid (Aβ), according...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.